Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why Did Genus Plc LSE:GNS Rise 2.27% Amid a firmer tone across London-listed animal genetics shares?

Genus Plc — LSE:GNS closed 2.27% higher on03 September 2026, with the shares at 2,342.00p after a gain of 52.00p on the day.

Ishan Mudgal | 03 September 2026

Why Did Hikma Pharmaceuticals Plc LSE:HIK Rise 0.12% Amid a firmer tone across London-listed pharmaceutical shares?

Hikma Pharmaceuticals Plc — LSE:HIK closed 0.12% higher on03 September 2026, with the shares at 1,617.00p after a gain of 2.00p on the day.

Ishan Mudgal | 03 September 2026

Why Did Allergy Therapeutics Plc LSE:AGY Rise 1.48% Amid a firmer tone across London-listed pharmaceutical shares?

Allergy Therapeutics Plc — LSE:AGY closed 1.48% higher on03 September 2026, with the shares at 5.500p after a gain of 0.080p on the day.

Ishan Mudgal | 03 September 2026

Why Did EKF Diagnostics Holdings Plc LSE:EKF Fall 1.69% Amid a softer tone across London-listed diagnostics shares?

EKF Diagnostics Holdings Plc — LSE:EKF closed 1.69% lower on03 September 2026, with the shares at 24.87p after a decline of 0.43p on the day.

Ishan Mudgal | 03 September 2026

PureTech Health PLC (LSE:PRTC) in Focus: Is This a Biotech Story the Market Is Underestimating?

The question for London investors is whether the market has caught up. At 31 March 2026 PureTech held $248.1m of parent-level cash, and its stake in newly listed Seaport Therapeutics was worth roughly $300m at that company's IPO price. Against that sits aMarket Capitalisationof …

Ankur Sharma | 03 September 2026

Why Oxford Nanopore Technologies Plc (LSE:ONT) Could Be a UK Technology Stock to Watch in 2026

Revenue for the six months to 30 June 2026 rose 12.3% at constant currency to £116.7m, grossMarginclimbed 400 basis points to 62.2% and the adjusted EBITDA loss more than halved to £22.1m. With a new chief executive six months into the job, a $20m …

Ankur Sharma | 03 September 2026

Oxford BioDynamics Plc (OBD): Could This London Stock Be One of 2026's Most Overlooked Stories?

Oxford BioDynamics Plc (LSE:OBD) has spent August 2026 pulling itself back from the edge. On 10 August the 3D-genomics diagnostics group said its cash would run out by early September without a £9.15m placing at just 0.1p a share, a deal handing new investors …

Ankur Sharma | 03 September 2026

Why Faron Pharmaceuticals Oy (FARN) Could Be a Healthcare Stock to Watch in 2026

That money matters because in March the FY2025 accounts warned that funds would last only until the second quarter of 2026, a going-concern uncertainty the rights issue has since removed. With a placebo-controlled Phase 2b study, BEXERA, due to start in the second half …

Divya Sood | 03 September 2026

Is Cambridge Nutritional Sciences PLC (LSE:CNSL) a Sleeper Stock Investors Should Be Watching in 2026?

That obscurity is precisely why some investors hunt in this corner of the London Stock Exchange. The immediate question is whether the Ely-based group can turn improving gross margins and growth in the UK and India into a return to profitability, at a moment …

Ankur Sharma | 03 September 2026

Is Craneware plc (LSE:CRW) a Sleeper Stock Investors Should Be Watching in 2026?

Full-year results are due this month, and the central question is whether the slippage in 340B and enterprise contract revenue is a timing problem, as management insists, or a sign of a tougher market.

Ankur Sharma | 03 September 2026
Support

Hi! How can we help you today?

Loading…